SION · Sionna Therapeutics, Inc.
$46.55
+1.17 (+2.58%)
At close · Jul 28
Market Cap
$2.10B
Shares
45.15M
Positioning
Aug 21, 2026 · 23 days to expiry · 26 contractsPut / call OI
0.99
Balanced positioning
Open interest
951
contracts outstanding
Volume
483
traded today
Max pain
$45.00
$1.55 below spot
ATM implied vol
349.4%
market's expected move
Open interest by strike
Calls
Puts
17.5
20
22.5
25
30
35
40
45
50
55
60
65
70
Chain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 0 | — | 282.5% | 0.961 | — | $1.50 | -0.057 | 352.9% | 100 | 101 | |
| 0 | — | 306.1% | 0.935 | — | $2.10 | -0.081 | 365.7% | 1 | 100 | |
| 0 | — | 315% | 0.91 | — | $2.40 | -0.1 | 357.3% | 4 | 100 | |
| 5 | 1 | 330.9% | 0.883 | $20.16 | $3.90 | -0.122 | 360% | 1 | 51 | |
| 2 | 1 | 325.8% | 0.835 | $21.20 | $6.00 | -0.167 | 351% | 4 | 15 | |
| 9 | 2 | 331.8% | 0.784 | $17.80 | $9.20 | -0.214 | 353.8% | 1 | 36 | |
| 1 | 1 | 328.6% | 0.735 | $15.51 | $10.00 | -0.26 | 353.3% | 1 | 51 | |
| 4 | 1 | 338.8% | 0.689 | $12.20 | $14.47 | -0.303 | 360% | 2 | 18 | |
| 178 | 178 | 325.8% | 0.638 | $14.47 | — | -0.343 | 362.9% | — | 0 | |
| 40 | 1 | 320% | 0.591 | $12.07 | — | -0.383 | 358.8% | — | 0 | |
| 53 | 2 | 329.9% | 0.555 | $11.30 | — | -0.416 | 365.3% | — | 0 | |
| 183 | 178 | 342.1% | 0.525 | $10.87 | — | -0.444 | 375.4% | — | 0 | |
| 2 | 2 | 338.3% | 0.491 | $9.20 | $29.70 | -0.474 | 376.2% | 2 | 2 | |
About this data
Greeks, implied volatility, open interest and the last price come from the latest daily snapshot and are 15-minute delayed. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown. Max pain is the listed strike where the most open interest would expire worthless — a positioning reference, not a forecast.
Key facts
CIK
2036042
CUSIP
829401108
13F (30d)
13 filings
13 filers
Visit website
Investor relations